MicroRNA Study Yields Potential Marker for Oligometastases Treatment Success | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The expression of microRNAs in the miR-200 family is elevated in oligometastases cases that fail to respond to aggressive treatment, according to a study appearing online last night in PLoS ONE, suggesting miRNA markers may help guide treatment for individuals with this type of metastasis.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.